FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. What is offered is the use of gamma modification of glycine for making a biologically effective preparation reducing catalepsy response time, anxienty, and enhancing exploratory motivation.
EFFECT: invention provides considerably decreasing the amount of used glycine with therapeutic retention.
1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF GLYCIN AND METHOD FOR PREPARING IT | 2010 |
|
RU2452480C2 |
METHOD FOR PRODUCTION OF GAMMA GLYCINE FROM SOLUTIONS | 2011 |
|
RU2471372C1 |
METHOD OF PRODUCING GAMMA-GLYCINE FROM SOLUTIONS | 2011 |
|
RU2470913C1 |
METHOD FOR PREPARING GAMMA-GLYCINE FROM SOLUTIONS | 2011 |
|
RU2480450C1 |
METHOD OF PRODUCING GAMMA-GLYCINE FROM SOLUTIONS | 2011 |
|
RU2462452C1 |
ANTISTRESS, STRESS-PROTECTIVE, NOOTROPIC AGENT, METHOD OF PROPHYLAXIS AND TREATMENT OF STRESS STATES AND A METHOD OF MENTAL WORKIN CAPACITY INCREASE | 1992 |
|
RU2025124C1 |
PEPTIDE POSSESSING NEUROTROPIC PROPERTIES | 2011 |
|
RU2443711C1 |
METHOD OF TESTING PREPARATIONS WITH POTENTIAL PSYCOTROPIC OR ACT-PROTECTIVE ACTION | 2015 |
|
RU2601376C1 |
METHOD FOR PREPARING FINE PHARMACEUTICAL COMPOSITIONS OF SALBUTAMOL | 2012 |
|
RU2504370C1 |
PHARMACEUTICAL COMPOSITION BASED ON N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE | 2017 |
|
RU2689396C2 |
Authors
Dates
2012-04-20—Published
2010-10-20—Filed